| Filed On | Filing |
|---|---|
| 16 Nov 2026 | 144 |
| 16 Nov 2026 | SCHEDULE 13G |
| 13 Nov 2026 | SCHEDULE 13G/A |
| 13 Nov 2026 | Form 4 |
| 13 Nov 2026 | Form 4 |
| 13 Nov 2026 | SCHEDULE 13G/A |
| 12 Nov 2026 | 144 |
| 05 Nov 2026 |
Form 4: Mulligan Brendan, General Counsel and Secretary
Sold 11,599 shares ($247K) |
| 05 Nov 2026 |
Form 4: Herb Tyler, Chief Accounting Officer
Sold 1,107 shares ($23.5K) · Sold 1,107 shares ($24.4K) |
| 04 Nov 2026 | 10-Q |
| 04 Nov 2026 |
8-K: Results of Operations and Financial Condition
Q3 revenue grew 43% year-over-year to $391.4 million, $16.4 million above the high-end of prior guidance. |
| 03 Nov 2026 |
Form 4: Voskanian Shaunt, Chief Revenue Officer
Gave up 12,007 shares to cover exercise price or tax ($260K) |
| 03 Nov 2026 |
Form 4: Melwani Praveer, CFO and Treasurer
Gave up 11,171 shares to cover exercise price or tax ($242K) |
| 03 Nov 2026 |
Form 4: Herb Tyler, Chief Accounting Officer
Gave up 2,872 shares to cover exercise price or tax ($62.2K) |
| 03 Nov 2026 |
Form 4: Mulligan Brendan, General Counsel and Secretary
Gave up 12,019 shares to cover exercise price or tax ($260K) |
| 03 Nov 2026 | 144 |
| 19 Oct 2026 |
Form 4: Radakovich Lynn Vojvodich, Director
Received 20,266 shares by exercise or conversion ($5.76K) · Sold 20,266 shares ($459K) |
| 15 Oct 2026 | 144 |
| 13 Oct 2026 | 144 |
| 07 Oct 2026 |
Form 4: Herb Tyler, Chief Accounting Officer
Sold 1,418 shares ($30.7K) |
Loading...